News | June 01, 2026
Indoco's formulation plant at Baddi receives EU GMP certification
This certification confirms that the facility complies with Good Manufacturing Practice requirements as referred in the EC Directive
This certification confirms that the facility complies with Good Manufacturing Practice requirements as referred in the EC Directive
The device screens for conditions like diabetic retinopathy, glaucoma, age-related macular degeneration, cataract and refractive error, in under ten minutes per patient
Net profit stood at Rs. 921 crore for the quarter, while Europe revenues surged 30.2% YoY to Rs. 2,795 crore
The certification follows an inspection conducted by the Malta Medicines Authority between January 29, 2026, and February 3, 2026
Around 2,000 runners participated in the awareness run organised during World Retinoblastoma Awareness Week
The company highlights role of integrated genomics and multi-omics research at the Illumina Multiomics Summit India 2026 held in New Delhi and Bengaluru
The transaction marks a clear portfolio reshuffle for Indoco
Over the past decade, IIL has maintained a strong growth trajectory, registering a compound annual growth rate (CAGR) of 16%
VESCOP, ENTOD Pharmaceuticals, and APTI-MSB host the event to bridge lab-to-clinic gap in eye care
Consensus calls for nationwide adoption of potassium-enriched salt to reduce cardiovascular disease risk
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
